InvestorsHub Logo
Followers 0
Posts 2
Boards Moderated 0
Alias Born 08/10/2020

Re: None

Monday, 08/10/2020 12:18:47 PM

Monday, August 10, 2020 12:18:47 PM

Post# of 272
73k CDI episodes of 2+ recurrences/year in US as studied in current study. Another 100k/year primary recurrence cases being studied in open label extension trial. Will SER-109 eventually be studied and used for the other 439k/year CDI patients in US to prevent any recurrences?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MCRB News